- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Advances in the Treatment of HER2-Positive Breast Cancer
December 18, 2014
William J. Gradishar, MD
William J. Gradishar, MD
Special Reports, Breast Cancer (Issue 1), Volume 1, Issue 1
William J. Gradishar, MD, discusses advances in the last year in the treatment of patients with HER2-positive breast cancer.
William J. Gradishar, MD, Betsy Bramsen Professorship of Breast Oncology, Professor in Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, discusses advances in the last year in the treatment of patients with HER2-positive breast cancer.
<<<